About Vitadio
Vitadio is a company based in Prague (Czechia) founded in 2017 by Bolek Kristian, Jan Somvarsky, Lucie Kovarova, Lenka Rohryova, and Ondrej Kulatka. Vitadio has raised $3.34 million across 1 funding round from investors including Theras Group. Vitadio offers products and services including Vitadio App and Digital Therapy Program. Vitadio operates in a competitive market with competitors including BeatO, Glooko, Fitterfly, Health2Sync and Dr. Diary Co, among others.
- Headquarter Prague, Czechia
- Founders Bolek Kristian, Jan Somvarsky, Lucie Kovarova, Lenka Rohryova, Ondrej Kulatka
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vitadio Sro
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.34 M (USD)
in 1 rounds
-
Latest Funding Round
$3.34 M (USD), Series A
Jul 24, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vitadio
Vitadio offers a comprehensive portfolio of products and services, including Vitadio App and Digital Therapy Program.
AI-driven tool for managing type 2 diabetes via personalized lifestyle changes.
Evidence-based program for reversing insulin resistance through habit building.
People of Vitadio
Unlock access to complete
Funding Insights of Vitadio
Vitadio has successfully raised a total of $3.34M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.34 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vitadio
Vitadio has secured backing from 1 investor. Prominent investors backing the company include Theras Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Develops medical technologies for diabetes, chronic pain, and weight management solutions.
|
Locked | Locked | Locked |
Investor details for Vitadio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vitadio
Investment portfolio details for Vitadio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vitadio
Detailed financials for Vitadio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vitadio Comparisons
Peer comparison for Vitadio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vitadio
Vitadio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeatO, Glooko, Fitterfly, Health2Sync and Dr. Diary Co, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smartphone-enabled glucometers and diabetes management apps are provided.
|
|
| Locked | Locked | Locked |
Diabetes management is enabled via glucose meters and mobile apps.
|
|
| Locked | Locked | Locked |
A mobile app is offered for managing multiple chronic diseases.
|
|
| Locked | Locked | Locked |
Provider of an app for tracking blood glucose level
|
|
| Locked | Locked | Locked |
Provider of app for diabetes management
|
|
| Locked | Locked | Locked |
Offers cloud-based SaaS for diabetes management and insulin dosing in hospitals.
|
Detailed competitors of Vitadio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vitadio
Complete news archive for Vitadio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vitadio
Vitadio was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Vitadio is headquartered in Prague, Czechia.
Vitadio is a funded company, having raised a total of $3.34M across 1 funding round to date.
Vitadio was founded in 2017 in Prague, Czech Republic, as a health technology company focused on diabetes care. An online platform is operated to assist patients in managing weight, controlling glucose levels, and reducing blood sugar and HbA1c. Information on treatments and habit-building strategies is delivered, with support from personal dietitians available via chat and video consultations. Operations target improved quality of life for diabetic individuals across the region.
Vitadio offers Vitadio App and Digital Therapy Program.
Vitadio has 1 investor. Key investors include Theras Group.